Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Glencore startet Aktienrückkaufprogramm von bis zu 1 Milliarde US-Dollar (Cash) +++ GLENCORE Aktie -3,74%

UCB Aktie

 >UCB Aktienkurs 
167.8 EUR    -0.7%    (Tradegate)
Ask: 168.1 EUR / 100 Stück
Bid: 167.95 EUR / 100 Stück
Tagesumsatz: 88 Stück
Realtime Kurs von 8 bis 22 Uhr!
UCB Aktie über LYNX handeln
>UCB Performance
1 Woche: -0,5%
1 Monat: +4,8%
3 Monate: +13,4%
6 Monate: -11,6%
1 Jahr: +19,2%
laufendes Jahr: -11,2%
>UCB Aktie
Name:  UCB S.A.
Land:  Belgien
Sektor:  Gesundheit
ISIN/ Wkn:  BE0003739530 / 852738
Symbol/ Ticker:  UNC (Frankfurt)
Kürzel:  FRA:UNC, ETR:UNC, UNC:GR
Index:  -
Webseite:  https://www.ucb.com/
Marktkapitalisierung:  31060 Mio. EUR
Umsatz:  6150 Mio. EUR
EBITDA:  1490 Mio. EUR
Gewinn je Aktie:  5.48 EUR
Schulden:  3030 Mio. EUR
Liquide Mittel:  1670 Mio. EUR
Umsatz-/ Gewinnwachstum:  26.2% / 2%
KGV/ KGV lG:  29.35 / 21.37
KUV/ KBV/ PEG:  5.09 / 3.05 / 2.71
Gewinnm./ Eigenkapitalr.:  17.31% / 11.21%
Dividende je Aktie:  1.39 EUR
Dividendenrendite/ -schätzung:  0.9% / 0.86%
Div. Historie:  25.04.25 - 1.39€
26.04.24 - 1.36€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  UCB
Letzte Datenerhebung:  07.07.25
>UCB Eigentümer
Aktien: 190.04 Mio. St.
f.h. Aktien: 119.95 Mio. St.
Insider Eigner: 36.25%
Instit. Eigner: 38.84%
Leerverk. Aktien: -
 >UCB Anleihen 
Es sind 2 Anleihen zur UCB Aktie bekannt.
>UCB Peer Group

 
02.07.25 - 14:48
UCB upgraded to “buy” as BofA raises Bimzelx sales forecast above consensus (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
27.06.25 - 22:33
United Community Banks, Inc. Announces Date for Second Quarter 2025 Earnings Release and Conference Call (GlobeNewswire EN)
 
GREENVILLE, S.C., June 27, 2025 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) announces it will release its second quarter 2025 financial results on Wednesday, July 23, 2025, before the stock market opens. The company also will hold a conference call at 9:00 a.m. EST on Wednesday, July 23, 2025, to discuss its financial results, business highlights, and outlook....
27.06.25 - 13:02
UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder (PR Newswire)
 
Phase 3 study met primary and most key secondary clinical endpoints This marks the third developmental and epileptic encephalopathies (DEE) population for fenfluramine with positive phase 3 results Results underscore the impact of UCB's continued investment in scientific innovation to......
23.06.25 - 19:00
United Community Banks (UCB) Could Be a Great Choice (Zacks)
 
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does United Community Banks (UCB) have what it takes? Let's find out....
23.06.25 - 10:57
UCB jumps over 4% after Morgan Stanley upgrades to “overweight” (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
20.06.25 - 13:01
UCB presents latest thymidine kinase 2 deficiency (TK2d) research at the United Mitochondrial Disease Foundation (UMDF) 2025 Conference (PR Newswire)
 
UCB will contribute three presentations, including data on the disease course of thymidine kinase 2 deficiency (TK2d) in untreated patients and insights into caregiver impact These data emphasize UCB's commitment to advancing treatment outcomes and patient experiences in TK2d and......
17.06.25 - 14:24
Inaugural 2025 UCB U.S. Myasthenia Gravis Scholarship™ grants 15 scholarships to people impacted by myasthenia gravis in the U.S. (PR Newswire)
 
ATLANTA, June 17, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that 15 scholarships were awarded to people impacted by myasthenia gravis in the U.S. The UCB Myasthenia Gravis Scholarship™ exemplifies UCB's dedication to supporting the rare disease......
12.06.25 - 18:33
UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity (PR Newswire)
 
Committed to serve U.S. patients and deliver economic impact of approximately $5 billion, including creation of 300 U.S. direct high skilled jobs and more than 500 construction jobs Scaling up U.S. based Contract Manufacturing Organization (CMO) partnerships to support the growth of UCB's......
12.06.25 - 18:18
Biogen, UCB Take A Leap In Lupus With Promising Phase 3 Results (Benzinga)
 
UCB and Biogen's lupus candidate showed strong Phase 3 results, including fatigue improvement and higher remission versus standard care. read more...
12.06.25 - 08:12
UCB & Biogen: Phase 3 Trial Of Dapirolizumab Pegol In Systemic Lupus Erythematosus Meets Main Goal (AFX)
 
WESTON (dpa-AFX) - UCB (UCB) and Biogen Inc. (BIIB) presented additional detailed results from the Phase 3 PHOENYCS GO study evaluating dapirolizumab pegol (DZP), a novel Fc-free anti-CD40L drug c......
12.06.25 - 07:03
Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity (GlobeNewswire EN)
 
BRUSSELS and CAMBRIDGE, Mass., June 12, 2025 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (NASDAQ: BIIB) today presented additional detailed results from the Phase 3 PHOENYCS GO study evaluating dapirolizumab pegol (DZP), a novel Fc-free anti-CD40L drug candidate. In the study, DZP demonstrated significant clinical improvements in disease activity in people living with moderate-to-severe systemic lupus erythematosus (SLE), as measured by the British Isles Lupus Assessment Group (BILAG)-based Composite Lupus Assessment (BICLA) at Week 48, the primary endpoint. Improvements were also seen across additional clinical measures, including fatigue and disease activity/remission. These results were presented at EULAR 2025, the European Alliance of Associations for Rheumatology's annual meeting, in Barcelona, Spain. The safety and efficacy of DZP in SLE have not been established, and it is not approved for use in SLE by any regulatory authority worldwide. A second Phase 3 trial of dapirolizu...
03.06.25 - 19:45
All You Need to Know About United Community Banks (UCB) Rating Upgrade to Buy (Zacks)
 
United Community Banks (UCB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....
03.06.25 - 19:00
Are You Looking for a High-Growth Dividend Stock? (Zacks)
 
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does United Community Banks (UCB) have what it takes? Let's find out....
19.05.25 - 18:33
UCB and Domino Data Lab Collaborate to Modernize Statistical Computing Environment in Life Sciences (PR Newswire)
 
Collaboration Blends Advanced Cloud Technologies, Open-Source Collaboration, and Data Science Integration to support UCB's development pipeline BRUSSELS and SAN FRANCISCO, May 19, 2025 /PRNewswire/ -- UCB, a global biopharmaceutical company, and Domino Data Lab, provider of a leading data......
15.05.25 - 22:18
United Community Banks, Inc. Announces Quarterly Cash Dividend on Common and Preferred Stock (GlobeNewswire EN)
 
GREENVILLE, S.C., May 15, 2025 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) (“United”, the “Company”), reported that its Board of Directors approved a quarterly cash dividend of $0.24 per share on the Company's common stock. The dividend is payable July 3, 2025 to shareholders of record as of June 15, 2025....
14.05.25 - 19:00
Why United Community Banks (UCB) is a Great Dividend Stock Right Now (Zacks)
 
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does United Community Banks (UCB) have what it takes? Let's find out....
01.05.25 - 13:33
United Community Banks, Inc. Announces Completion of Merger With ANB Holdings, Inc., The Parent of American National Bank (GlobeNewswire EN)
 
GREENVILLE, S.C., May 01, 2025 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) (“United”) completed its merger with ANB Holdings, Inc. (“ANB”) effective May 1, 2025. In this transaction, ANB's wholly-owned bank subsidiary, American National Bank (“ANB Bank”), was also merged into United's bank subsidiary, United Community Bank (“United Community”). ANB Bank will operate under the United Community brand after all core systems, signage, and branding are converted to those of United Community on the weekend of July 11, 2025....
28.04.25 - 19:00
Why United Community Banks (UCB) is a Top Dividend Stock for Your Portfolio (Zacks)
 
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does United Community Banks (UCB) have what it takes? Let's find out....
24.04.25 - 23:57
XFRA: DIVIDEND/INTEREST INFORMATION - 25.04.2025 - BE0003739530 (XETRA)
 
Das Instrument UNC BE0003739530 UCB S.A. EQUITY wird ex Dividende/Zinsen gehandelt am 25.04.2025 The instrument UNC BE0003739530 UCB S.A. EQUITY has its ex-dividend/interest day on 25.04.2025...
22.04.25 - 16:45
United Community Banks (UCB) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
 
While the top- and bottom-line numbers for United Community Banks (UCB) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Es geht nichts über ein ruhiges Leben, wie der Mann sagte, als er die Stelle eines Leuchtturmwärters annahm. - Charles Dickens
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!